Medicare Enrolled
Dr. Steven Baumgarten, M.D.
Pulmonary Disease · Cherry Hill, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Baumgarten from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Baumgarten?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Baumgarten
Dr. Steven Baumgarten is a pulmonary disease specialist in Cherry Hill, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Baumgarten performed 1,866 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Baumgarten received a total of $8,216 from 38 pharmaceutical and/or device companies across 517 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Baumgarten is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 39% volume in NJ
$8,216 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,866
Medicare services
Top 39% in NJ for pulmonary disease
Not available
Unique patients (not deduplicated)
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
556 | $67 | $164 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
488 | $94 | $284 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
202 | $181 | $596 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
128 | $109 | $291 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
102 | $48 | $185 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
99 | $38 | $145 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
62 | $32 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
55 | $134 | $365 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
52 | $29 | $110 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
51 | $24 | $120 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $68 | $200 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
18 | $101 | $246 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $148 | $430 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $155 | $395 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$8,216
Total received (2018-2024)
Avg $1,174/year across 7 years
Top 16% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
517
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,573
2023
$1,396
2022
$1,838
2021
$848
2020
$649
2019
$942
2018
$969
Payments by company (2024)
GlaxoSmithKline, LLC.
$477
AstraZeneca Pharmaceuticals LP
$397
GENZYME CORPORATION
$145
Mylan Specialty L.P.
$100
Axsome Therapeutics, Inc.
$64
Actelion Pharmaceuticals US, Inc.
$63
HARMONY BIOSCIENCES LLC
$63
Regeneron Healthcare Solutions, Inc.
$58
Baxter Healthcare
$39
Inspire Medical Systems, Inc.
$38
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
Exact Sciences Corporation
$30
Insmed, Inc.
$30
Philips North America LLC
$22
Paratek Pharmaceuticals, Inc.
$14
Top 3 companies account for 64.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,039
GlaxoSmithKline, LLC.
$1,881
Mylan Specialty L.P.
$542
Boehringer Ingelheim Pharmaceuticals, Inc.
$391
Actelion Pharmaceuticals US, Inc.
$356
Inari Medical, Inc.
$332
GENZYME CORPORATION
$309
Genentech USA, Inc.
$247
Regeneron Healthcare Solutions, Inc.
$244
United Therapeutics Corporation
$231
Novartis Pharmaceuticals Corporation
$174
Insmed, Inc.
$127
Philips Electronics North America Corporation
$121
Electromed, Inc.
$121
Axsome Therapeutics, Inc.
$98
Teva Pharmaceuticals USA, Inc.
$88
Harmony Biosciences LLC
$87
Baxter Healthcare
$85
Merck Sharp & Dohme LLC
$85
Grifols USA, LLC
$82
HARMONY BIOSCIENCES LLC
$77
JAZZ PHARMACEUTICALS INC.
$72
Amgen Inc.
$62
Paratek Pharmaceuticals, Inc.
$40
Inspire Medical Systems, Inc.
$38
Advanced Respiratory, Inc
$36
Bayer Healthcare Pharmaceuticals Inc.
$36
Exact Sciences Corporation
$30
Pulmonx Corporation
$30
PFIZER INC.
$29
Gilead Sciences, Inc.
$24
Philips North America LLC
$22
Pharming Healthcare, Inc.
$15
Alexion Pharmaceuticals, Inc.
$15
Mallinckrodt Enterprises LLC
$13
AbbVie Inc.
$13
Janssen Pharmaceuticals, Inc
$12
Sunovion Pharmaceuticals Inc.
$12
Top 3 companies account for 54.3% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · AirDuo Digihaler · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · Cologuard Collection Kit · DUPIXENT · Dymista · ELIQUIS · Esbriet · FARXIGA · FASENRA · FLOWTRIEVER CATHETER · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INSPIRE · Life 2000 Ventilation System · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Prolastin-C Liquid · RUCONEST · Respiratoriy Care Undiv · S · SMARTVEST · SOLIRIS · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · VRAYLAR · WAKIX · Wakix · XARELTO · XOLAIR · XYWAV · Xolair · YUPELRI · Yupelri · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
275
County median income
$86,384
Nearest hospital to ZIP centroid (approximate)
WEST JERSEY HOSPITAL
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Baumgarten is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Baumgarten experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Baumgarten performed 556 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Baumgarten receive payments from pharmaceutical companies?
Yes. Dr. Baumgarten received a total of $8,216 from 38 companies across 517 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Baumgarten's costs compare to other pulmonary diseases in Cherry Hill?
Dr. Baumgarten's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Baumgarten) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Cherry Hill
Browse pulmonary diseases in Cherry Hill ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NJ
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NJ
Which NJ pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Mylan Specialty L.P. Payments to Doctors
See all physicians who received payments from Mylan Specialty L.P.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology